C19ORF52 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.828800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.326000E-01
Normal-vs-Stage2
3.961600E-01
Normal-vs-Stage3
6.187000E-01
Normal-vs-Stage4
2.028200E-01
Stage1-vs-Stage2
8.662200E-01
Stage1-vs-Stage3
2.148400E-01
Stage1-vs-Stage4
5.378800E-01
Stage2-vs-Stage3
9.426200E-02
Stage2-vs-Stage4
3.482200E-01
Stage3-vs-Stage4
1.695410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.086200E-01
Normal-vs-AfricanAmerican
6.029400E-01
Normal-vs-Asian
3.461700E-02
Caucasian-vs-AfricanAmerican
4.218800E-01
Caucasian-vs-Asian
5.718100E-02
AfricanAmerican-vs-Asian
1.549710E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.600800E-01
Normal-vs-Female
4.272600E-01
Male-vs-Female
9.096600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.930600E-01
Normal-vs-Age(41-60Yrs)
2.557800E-01
Normal-vs-Age(61-80Yrs)
5.210000E-01
Normal-vs-Age(81-100Yrs)
1.295750E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.246600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.217600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.836200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.437840E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.598000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.297600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.327600E-01
Normal-vs-Daily Drinker
3.712600E-01
Normal-vs-Weekly Drinker
2.590600E-01
Normal-vs-Occasional Drinker
3.938000E-01
Normal-vs-Social Drinker
6.980500E-02
Non Drinker-vs-Daily Drinker
6.925800E-01
Non Drinker-vs-Weekly Drinker
6.058600E-01
Non Drinker-vs-Occasional Drinker
8.753400E-01
Non Drinker-vs-Social Drinker
5.906800E-01
Daily Drinker-vs-Weekly Drinker
8.922400E-01
Daily Drinker-vs-Occasional Drinker
8.358400E-01
Daily Drinker-vs-Social Drinker
8.564800E-01
Weekly Drinker-vs-Occasional Drinker
7.340600E-01
Weekly Drinker-vs-Social Drinker
9.563400E-01
Occasional Drinker-vs-Social Drinker
7.216200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.480800E-01
Normal-vs-Grade 2
8.481200E-01
Normal-vs-Grade 3
7.673200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.913800E-01
Grade 1-vs-Grade 3
2.390400E-01
Grade 1-vs-Grade 4
8.480800E-01
Grade 2-vs-Grade 3
4.848300E-02
Grade 2-vs-Grade 4
8.481200E-01
Grade 3-vs-Grade 4
7.673200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.985800E-01
Normal-vs-NonDiabetic
2.777600E-01
Diabetic-vs-NonDiabetic
2.688800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.687800E-02
Normal-vs-NoPancreatitis
3.925200E-01
Pancreatitis-vs-NoPancreatitis
7.680100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.269600E-01
Normal-vs-N1
4.544200E-01
N0-vs-N1
2.086400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.04389999999877E-05
Normal-vs-TP53-NonMutant
1.281980E-02
TP53-Mutant-vs-TP53-NonMutant
2.069500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
